Published in Genet Anal on February 01, 1999
The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.99
Databases and QSAR for cancer research. Cancer Inform (2007) 0.79
Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res (1994) 5.64
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J (2001) 4.70
Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control (2008) 4.37
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene (2007) 4.27
Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature (1982) 4.22
IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res (1998) 3.74
Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A (1986) 3.42
Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A (1998) 3.35
In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol (1983) 2.91
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res (1996) 2.65
Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell (1985) 2.58
The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (1994) 2.49
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun (1992) 2.47
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics (1992) 2.45
Heterogeneous distribution of filipin--cholesterol complexes across the cisternae of the Golgi apparatus. Proc Natl Acad Sci U S A (1981) 2.45
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun (1991) 2.25
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res (1997) 2.17
Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09
Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci U S A (1990) 2.07
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol (1990) 2.00
Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci (1995) 1.98
Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev Biol (1998) 1.90
Recent advances in p53 research: an interdisciplinary perspective. Cancer Gene Ther (2008) 1.88
Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst (1997) 1.86
Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. J Natl Cancer Inst (1977) 1.86
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A (1993) 1.84
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer (1996) 1.82
Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer (1989) 1.80
Phalloidin-induced hyperplasia of actin filaments in rat hepatocytes. Lab Invest (1975) 1.78
New approaches to understanding p53 gene tumor mutation spectra. Mutat Res (1999) 1.75
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ (2011) 1.74
Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res (2000) 1.73
Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977). Cancer Res (1978) 1.73
Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol (1999) 1.70
Respiratory tract carcinogenesis in hamsters induced by different numbers of administrations of benzo(a)pyrene and ferric oxide. Cancer Res (1972) 1.67
Absence of filipin-sterol complexes from large coated pits on the surface of culture cells. Proc Natl Acad Sci U S A (1979) 1.67
Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium. Nature (1975) 1.66
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer (1967) 1.61
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res (1997) 1.58
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer (1992) 1.57
Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains. Int J Cancer (1975) 1.53
In vivo assembly of tight junctions in fetal rat liver. J Cell Biol (1975) 1.53
Liver-microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride. Biochem Biophys Res Commun (1975) 1.52
Relevance of nitrosamines to human cancer. Carcinogenesis (1984) 1.51
TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development (1994) 1.51
TP53: a key gene in human cancer. Biochimie (2002) 1.50
IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hum Mutat (1999) 1.48
Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem (1992) 1.47
Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res (1993) 1.45
Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J Cell Physiol (1985) 1.45
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Ther (2010) 1.41
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol (1995) 1.39
The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol (2007) 1.36
Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamine. Biochem J (1976) 1.35
Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol (1987) 1.35
Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis (2007) 1.34
Production of epithelial and mesenchymal tumours with rat liver cells transformed in vitro. Int J Cancer (1975) 1.33
Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids. J Cell Biol (1983) 1.33
Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res (1991) 1.32
Potential risk for dengue hemorrhagic fever: the isolation of serotype dengue-3 in Mexico. Emerg Infect Dis (1996) 1.31
Repair of O-alkylpyrimidines in mammalian cells: a present consensus. Proc Natl Acad Sci U S A (1988) 1.30
Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J Cell Physiol (1987) 1.30
An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J Biol Chem (1996) 1.30
Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res (1998) 1.29
Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr (1995) 1.27
p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter. Oncogene (2010) 1.26
Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett (2001) 1.25
Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res (1990) 1.24
Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. Int J Cancer (2000) 1.23
Mutagenicity of vinyl chloride, chloroethyleneoxide, chloroacetaldehyde and chloroethanol. Biochem Biophys Res Commun (1975) 1.23
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst (2000) 1.23
Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev (2013) 1.23
Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol (1984) 1.23
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.21
Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene (2000) 1.21
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell (2001) 1.21
Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol Cell Biol (1997) 1.19
Effect of chronic treatment of rats with dimethylnitrosamine on the removal of O6-methylguanine from DNA. Cancer Res (1980) 1.19
Workshop on DNA repair. Mutat Res (1992) 1.18
Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol (1993) 1.18
O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer (1985) 1.17
Respiratory tract carcinogenesis induced in hamsters by different dose levels of benzo-(a)pyrene and ferric oxide. J Natl Cancer Inst (1972) 1.16
Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis (1990) 1.15
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg (1992) 1.15
Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis (1986) 1.14
Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res (1988) 1.14
Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer (1997) 1.13
Opposite polarity of filipin-induced deformations in the membrane of condensing vacuoles and zymogen granules. Science (1980) 1.13
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene (2006) 1.13
Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem (1999) 1.12
Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene (2001) 1.12